Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3164)
All Articles published online
|
Oct 7, 2006 (publication date) through Jan 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Novacek G, Miehsler W, Palkovits J, Reinisch W, Waldhör T, Kapiotis S, Gangl A, Vogelsang H. Resistance to activated protein C is a risk factor for fibrostenosis in Crohn’s disease. World J Gastroenterol 2006; 12(37): 6026-6031 [PMID: 17009403 DOI: 10.3748/wjg.v12.i37.6026] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i37/6026.htm |
| Number | Citing Articles |
| 1 |
Calen A. Steiner, Jeffrey A. Berinstein, Jeremy Louissaint, Peter D.R. Higgins, Jason R. Spence, Carol Shannon, Cathy Lu, Ryan W. Stidham, Joel G. Fletcher, David H. Bruining, Brian G. Feagan, Vipul Jairath, Mark E. Baker, Dominik Bettenworth, Florian Rieder. Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn’s Disease: A Systematic Review. Clinical Gastroenterology and Hepatology 2022; 20(4): 817 doi: 10.1016/j.cgh.2021.05.054
|
| 2 |
Gottfried Novacek, Pavol Papay, Wolfgang Miehsler, Walter Reinisch, Cornelia Lichtenberger, Raute Sunder-Plassmann, Harald Vogelsang, Cornelia Gratzer, Christine Mannhalter. Are inherited thrombotic risk factors associated with fibrostenosis in Crohnʼs disease?. Inflammatory Bowel Diseases 2011; 17(12): 2505 doi: 10.1002/ibd.21648
|
| 3 |
Darina Kohoutova, Miroslav Pecka, Michal Cihak, Jiri Cyrany, Jaroslav Maly, Jan Bures. Prevalence of hypercoagulable disorders in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2014; 49(3): 287 doi: 10.3109/00365521.2013.870597
|